Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025

Rhea-AI Summary

Moderna (NASDAQ: MRNA) has announced its upcoming participation in the Barclays Speaking the Science Call Series, scheduled for Monday, June 16th, 2025, at 10:00 AM ET. Investors and interested parties can access the live webcast of the presentation through the 'Events and Presentations' section on Moderna's investor relations website at investors.modernatx.com. The presentation recording will remain available on the company's website for a minimum of 30 days after the event.

News Market Reaction

+0.25%

1 alert

+0.25% News Effect

On the day this news was published, MRNA gained 0.25%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event:

Barclays Speaking the Science Call Series, on Monday, June 16^th at 10:00am ET

A live webcast of this presentation will be available under "Events and Presentations" in the Investors section of the Moderna website.

investors.modernatx.com.

A replay of this webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

FAQ

When is Moderna presenting at the Barclays Speaking the Science Call Series?

Moderna will present at the Barclays Speaking the Science Call Series on Monday, June 16th, 2025, at 10:00 AM ET.

How can investors access Moderna's (MRNA) Barclays presentation?

Investors can access the live webcast through the 'Events and Presentations' section on Moderna's website at investors.modernatx.com.

How long will Moderna's (MRNA) Barclays presentation replay be available?

The webcast replay will be archived on Moderna's website for at least 30 days following the presentation.

What is the purpose of Moderna's participation in the Barclays Speaking the Science Call Series?

The event is an investor presentation where Moderna will discuss their scientific developments and provide updates to the investment community.